Bay Street News, November, 2018

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) — Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and […]

ANCHORAGE, Alaska, Nov. 30, 2018 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors […]

BURNABY, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that […]

SANTA CLARA, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) — Ambarella, Inc., (NASDAQ: AMBA),  a leading developer of low-power and high-resolution […]

MONTREAL, Nov. 30, 2018 (GLOBE NEWSWIRE) — Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people […]

Phase 3 elacestrant study has opened for enrollment Fast Track designation from the FDA for the Phase 3 study population […]

VANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) — Mundoro Capital Inc. (TSXV: MUN, www.mundoro.com) (“Mundoro” or the “Company“) is […]

GreenPower has Orders for over 40 EV Star and EV Star Plus Min-eBuses PORTERVILLE, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) […]

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) — SMAAASH Entertainment, Inc. (NASDAQ: SMSH) (“SMAAASH” or the “Company”), a global virtual […]

EMERYVILLE, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), a leader in the research, development and production of […]